Proteometer-UFT Kit
The Proteometer-UFT Kit runs an at-line titer measurement of mAbs in less than 90 seconds. It requires no sample preparation or Protein A and is utilized with a dual pump liquid chromatograph with a fluorescence detector (single pump systems are usable with minimal sample prep, no Protein A).
​
It solves several problems in drug development and clone selection by providing quick titer from clarified fermentation broth (CFB) while allowing users to maintain their standard workflow. It is also potentially more accurate than Protein A due to fewer sample manipulation steps.
​
The product is developed specifically for pharmaceutical scientists, engineers, and production managers to optimize pre- and post-Protein A purification testing. This very fast and accurate titer will provide an early warning that changes are happening in your manufacturing or sample preparation processes. It benefits Process R&D by allowing scientists to study the titer range quickly.
​
Features & Benefits
-
No system regeneration: Reduces analysis time & cost
-
No Protein A required: Hours to 90secs
-
Analysis of CFB samples: HCP removal no needed
-
Plugs into any LC: Easy adoption - no new software needed
-
No method development: Reduces time until method usage
-
No LC column required: Faster processing, long life
-
Adjustable titer range: One test for upstream & downstream
-
Low sample volume (≤ 20μL): Reduced impact on processing
-
At-line analysis: Reduces time between collection & analysis
Kit Components​​
-
MD Module
-
Standard Tee
-
Tubing Unions
-
Buffer Packets
-
Reagent Packets
-
DMF
-
Instructions for Use
​
Additional Product Information:
​
​
​
​
​
​
​
​
​​
​
​
​
​
​
​
​
​
​
​
​
​
​
​​
​
​
​
​
​
​
TESTIMONIALS
“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.
The approach improves product safety, reduces COPQ and post release testing, and paves the way for real-time product release, reducing inventory costs.
The solution combines novel sample handing and artificial intelligence with proven analytical technology that is easy to deploy and support, and provides near instantaneous ROI.”
Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)
"As analytical tools have matured for the quality control and characterization of isolated biopharmaceuticals, the application of advanced analytical systems to dynamically contribute to process monitoring and control in complex bioreactors is critical for enhanced process efficiency and product quality.
The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies. The integration of complementary bioprocess analytical data facilitates decision-making through a powerful link between the manufacturing space and the QC laboratory."